BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38588921)

  • 41. Long-term morbidity in children treated with fractionated high-dose-rate brachytherapy for soft tissue sarcomas.
    Nag S; Tippin D; Ruymann FB
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):448-52. PubMed ID: 12794522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy.
    Crook JM; Haie-Meder C; Demanes DJ; Mazeron JJ; Martinez AA; Rivard MJ
    Brachytherapy; 2013; 12(3):191-8. PubMed ID: 23453681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A National Referral Service for Paediatric Brachytherapy: An Evolving Practice and Outcomes Over 13 Years.
    Gaze MN; Smeulders N; Ackwerh R; Allen C; Bal N; Boutros M; Cho A; Eminowicz G; Gill E; Fittall MW; Humphries PD; Lim P; Mushtaq I; Nguyen T; Peet C; Pendse D; Polhill S; Rees H; Sands G; Shankar A; Slater O; Sullivan T; Hoskin PJ
    Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):237-244. PubMed ID: 36588012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma.
    Lobo S; Gaze MN; Slater O; Hoskin P; Sands G; Sullivan T; Cho A; Eminowicz G; Smeulders N
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29574. PubMed ID: 35044080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis.
    Schoot RA; Saeed P; Freling NJ; Blank LE; Pieters BR; van der Grient JN; Strackee SD; Bras J; Caron HN; Merks JH;
    Ophthalmic Plast Reconstr Surg; 2016; 32(5):354-60. PubMed ID: 26398242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols.
    Ferrari A; Trama A; De Paoli A; Bergeron C; Merks JHM; Jenney M; Orbach D; Chisholm JC; Gallego S; Glosli H; De Salvo GL; Botta L; Gatta G; Bisogno G;
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27882658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 3D CT-based high-dose-rate breast brachytherapy implants: treatment planning and quality assurance.
    Das RK; Patel R; Shah H; Odau H; Kuske RR
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1224-8. PubMed ID: 15234059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies.
    Rogers T; Zanetti I; Coppadoro B; Martelli H; Jenney M; Minard-Colin V; Terwisscha van Scheltinga SEJ; Skerritt C; Fajardo RD; Guérin F; Kelsey A; Merks JHM; Mandeville H; Guillén G; Glosli H; De Corti F; Bisogno G
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29739. PubMed ID: 35460336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology.
    van Ewijk R; Schoot RA; Sparber-Sauer M; Ter Horst SAJ; Jehanno N; Borgwardt L; de Keizer B; Merks JHM; de Luca A; McHugh K; von Kalle T; Schäfer JF; van Rijn RR;
    Pediatr Radiol; 2021 Sep; 51(10):1940-1951. PubMed ID: 34137936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical research on the treatment effects of radioactive (125)I seeds interstitial brachytherapy on children with primary orbital rhabdomyosarcoma.
    Ge X; Ma J; Dai H; Ren L; Li Q; Shi J
    Med Oncol; 2014 Sep; 31(9):27. PubMed ID: 25092038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma.
    Gallego S; Bernabeu D; Garrido-Pontnou M; Guillen G; Hindi N; Juan-Ribelles A; Márquez C; Mata C; Orcajo J; Ramírez G; Ramos M; Romagosa C; Ruano D; Rubio P; Vergés R; Valverde C;
    Clin Transl Oncol; 2021 Dec; 23(12):2460-2473. PubMed ID: 34212338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer.
    Vicini FA; Kestin LL; Edmundson GK; Jaffray DA; Wong JW; Kini VR; Chen PY; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):803-10. PubMed ID: 10524437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. American Brachytherapy Society consensus report for accelerated partial breast irradiation using interstitial multicatheter brachytherapy.
    Hepel JT; Arthur D; Shaitelman S; Polgár C; Todor D; Zoberi I; Kamrava M; Major T; Yashar C; Wazer DE
    Brachytherapy; 2017; 16(5):919-928. PubMed ID: 28676428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 10-year experience of pediatric brachytherapy.
    Healey EA; Shamberger RC; Grier HE; Loeffler JS; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):451-5. PubMed ID: 7772200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperfractionated radiation in children with rhabdomyosarcoma--results of an Intergroup Rhabdomyosarcoma Pilot Study.
    Donaldson SS; Asmar L; Breneman J; Fryer C; Glicksman AS; Laurie F; Wharam M; Gehan EA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):903-11. PubMed ID: 7607964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Innovation in the management of soft tissue sarcomas in infants and young children: high-dose-rate brachytherapy.
    Nag S; Martínez-Monge R; Ruymann F; Jamil A; Bauer C
    J Clin Oncol; 1997 Sep; 15(9):3075-84. PubMed ID: 9294470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What is new in rhabdomyosarcoma management in children?
    Gosiengfiao Y; Reichek J; Walterhouse D
    Paediatr Drugs; 2012 Dec; 14(6):389-400. PubMed ID: 23050743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brachytherapy in the combined modality treatment of pediatric malignancies. Principles and preliminary experience with treatment of soft tissue sarcoma (recurrence) and Ewing's sarcoma.
    Pötter R; Knocke TH; Kovacs G; Schmilowski GM; Haverkamp U; Hawliczek R; Seitz W; Rübe C; Wuisman P; Maragakis G
    Klin Padiatr; 1995; 207(4):164-73. PubMed ID: 7564147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States.
    Prete JJ; Prestidge BR; Bice WS; Friedland JL; Stock RG; Grimm PD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):1001-5. PubMed ID: 9531387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.